Investigators and institutions participating in the Acute heart failure Volume Control Multicenter rAndomized (AVCMA) trial are listed in the Appendix.
Acute heart failure volume control multicenter randomized (AVCMA) trial: Comparison of tolvaptan and carperitide
Article first published online: 19 OCT 2013
© 2013 The Authors. The Journal of Clinical Pharmacology Published by Wiley Periodicals, Inc. on behalf of The American College of Clinical Pharmacology
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
The Journal of Clinical Pharmacology
Volume 53, Issue 12, pages 1277–1285, December 2013
How to Cite
Suzuki, S., Yoshihisa, A., Yamaki, T., Sugimoto, K., Kunii, H., Nakazato, K., Abe, Y., Saito, T., Ohwada, T., Suzuki, H., Saitoh, S.-i., Kubota, I., Takeishi, Y. and on behalf of the AVCMA investigators (2013), Acute heart failure volume control multicenter randomized (AVCMA) trial: Comparison of tolvaptan and carperitide. Journal of Clinical Pharma, 53: 1277–1285. doi: 10.1002/jcph.197
- Issue published online: 14 NOV 2013
- Article first published online: 19 OCT 2013
- Manuscript Accepted: 23 SEP 2013
- Manuscript Received: 25 APR 2013
- Japanese Heart Foundation. Grant Number: 12100026
Additional supporting information may be found in the online version of this article at the publisher's web-site.
|jcph197-sm-0001-SuppFig-S1.pptx||71K||Figure S1. (A) Comparison of drug cost between tolvaptan and carperitide illustrated by cumulative distribution plots. (B) Comparison of mean drug cost per patient between tolvaptan and carperitide groups.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.